Conventional peptide drug has sometimes been constrained by suboptimal bioavailability and metabolic longevity. Despite this, emerging technologies are driving a genuine transformation in peptide engineering. These https://yxzbookmarks.com/story22060427/revolutionizing-medicinal-discovery-with-innovative-short-proteins